The other day I was reading an interesting article on Defensive Due Diligence by Claudine Cohen, Mendy Dwestel and Andrew Finkle (all from Grant Thornton) in the January 2010 of Mergers & Acquisitions publication of the Association for Corporate Growth. They make...
It seems my industry colleagues have been wrongly optimistic and also hyper cynical. At least that is the bottom line of the read I get in comparing the analysis of the 2nd annual Semaphore Confidence Survey with last year’s results. And some people have very...
The Valley of Death for a Life Sciences company is that space, as coined by the NCI’s Director of Small Business Innovation Research Programs Michael Weingarten, between a Phase 2 SBIR grant and the commercial success of the technology that is being funded and...
I field calls from GPs and CEOs all the time. Invariably they are doing a deal, whether investment or acquisition, and need either verification that the technology and/or markets targeted are real or a product exists and someone wishes to buy it in the future. Less...
Marketing Due Diligence Last Thursday there was a Happening…Monsters of Pork… at Petit Robert as part of a spectacular program of market oriented seminars and symposia under the brand Future M. The pork party was a real experience. I had been to the location before...
Hello, We have all had a new boss in our life. This is an announcement concerning a different sort of BOSS. We here at Semaphore are excited to let you know more about our Business Operations/Strategy Service and the addition of David Friend, M.D., MBA as part of our...
